WILLIAM PALMER: Open Payments
NPI 1285161539 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 31 payments from 11 companies in 2025. Trend: 2023 $921 · 2024 $861 · 2025 $1,333
Food & beverage: $1,008Consulting: $240Education: $85
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $290 |
| Ascensia Diabetes Care Us Inc. | 1 | $240 |
| UCB, Inc. | 3 | $164 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $139 |
| Lilly USA, LLC | 2 | $138 |
| LEO Pharma Inc. | 2 | $119 |
| PFIZER INC. | 2 | $117 |
| Incyte Corporation | 2 | $59 |
| ABBVIE INC. | 2 | $29 |
| Galderma Laboratories, L.P. | 1 | $19 |
Products named: DUPIXENT, Bimzelx, EBGLYSS, ANZUPGO, LITFULO, Opzelura, ILUMYA, CIBINQO.
Industry payments across GA — which companies pay providers there.
